Last reviewed · How we verify
NCT05501379: OncoPhys
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
trial testing No intervention - observational study only in Lymphoma in 60 participants. Currently enrolling.
31 December 2024
Quick facts
| Lead sponsor | University Medicine Greifswald |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 21 September 2022 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- No intervention - observational study only
Conditions studied
- Lymphoma — all drugs for Lymphoma →
- Pancreas Cancer — all drugs for Pancreas Cancer →
- Colorectal Cancer — all drugs for Colorectal Cancer →
Sponsor
University Medicine Greifswald
Who can join
18 and older, any sex, with Lymphoma or Pancreas Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Physical activity is an important aspect of cancer therapy but correct measurement of physical activity is difficult. In this study, the physical activity of patients undergoing cancer therapy is assessed by questionnaire and by motion tracker. The results are then compared to answer whether there are differences between the two measurements. Findings of this study will help to improve the assessment of physical activity in cancer patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05501379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention - observational study only
Trials testing the same drug.
- NCT05613673 — Prognostic Value of Different Nutritional Screening Tools in Acute Pancreatitis · active not recruiting
- NCT04476082 — Nutrition in Gastrointestinal Tumors · completed
Other recruiting trials for Lymphoma
Currently open trials in the same condition.
- NCT07302347 — A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participan · Phase 1, PHASE2 · recruiting
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT06856226 — Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing · recruiting
- NCT07226934 — An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers · NA · recruiting
- NCT07138547 — GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma · Phase 1, PHASE2 · recruiting
Other University Medicine Greifswald trials
Trials by the same sponsor.
- NCT06796374 — A Comparison of Fisetin Kinetics in Young and Old Adults · NA · recruiting
- NCT06970171 — Acceptance of Mandibular Advancement Devices · NA · not yet recruiting
- NCT06939608 — Kinetics of Yohimbine in Humans to Explore Sex and CYP2D6 Genotype Interactions · NA · completed
- NCT06273241 — Impact of Food Intake on Berberine Kinetics · NA · completed
- NCT06249451 — Staphylococcus Aureus Bacteraemia (SAB)-Support-Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05501379 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medicine Greifswald
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05501379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing